A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

AI can transform healthcare, but risks remain: liability, bias, blurred “wellness vs medicine,” and jagged model errors.

In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance ...

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in ...

SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

A major step toward simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to ...

There’s no doubt that large language models and generative AI tools have taken the world by storm. Their ability to create, ...

Whether a smartphone battery lasts longer or a new drug can be developed to treat incurable diseases depends on how stably the atoms constituting the material are bonded. The core of 'molecular design ...

CAMBRIDGE, Mass., February 12, 2026 - Insilico Medicine (3696.HK), a clinical-stage, generative AI-driven drug discovery company, today announced the launch of a new interactive webpage highlighting ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.